Post-prandial remnant lipoprotein metabolism in autosomal recessive hypercholesterolaemia

European Journal of Clinical Investigation

Volumn 42, Issue 10, 2012, Pages 1094-1099

  Tada, Hayato ^a   Kawashiri, Masa aki ^a   Tanaka, Akira ^b   Nakano, Takamitsu ^c   Nakajima, Katsuyuki ^c   Inoue, Takeshi ^a   Noguchi, Tohru ^d   Nakanishi, Chiaki ^a   Konno, Tetsuo ^a   Hayashi, Kenshi ^a   Nohara, Atsushi ^d   Inazu, Akihiro ^d   Kobayashi, Junji ^d   Mabuchi, Hiroshi ^d   Yamagishi, Masakazu ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KAGAWA NUTRITION UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Autosomal recessive hypercholesterolaemia; Familial hypercholesterolaemia; LDLR adaptor protein 1; Oral fat tolerance test; Remnant like particles

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE HYPERCHOLESTEROLAEMIA; BLOOD SAMPLING; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLAEMIA; FAMILIAL HYPERLIPEMIA; FEMALE; GENE MUTATION; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AREA UNDER CURVE; CHOLESTEROL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 84866283283     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2012.02700.x     Document Type: Article

References (23)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Diseases, 8th edn. New York: McGraw- Hill; 2001: pp 2863-913.
2. Soutar AK, Naoumova RP. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Pract Cardiovasc Med 2007;4:214-25.
3. Karpe F, Steiner G, Uffelmann K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994;106:83-97.
4. de Sauvage Nolting PR, Twickler MB, Dallings-Thie GM, Buirma RJ, Hutten BA, Kastelein JJ et al. Elevated remnant-like particles in heterozygous familial hypercholesterolemia and response to statin therapy. Circulation 2002;106:788-92.
5. Harada-Shiba M, Takagi A, Miyamoto Y, Tsushima M, Ikeda Y, Yokoyama S et al. Clinical features and genetic analysis of autosomal recessive hypercholesterolemia. J Clin Endocrinol Metab 2003;88:2541-7.
6. Soutar AK, Naoumova RP, Traub LM. Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol 2003;23:1963-70.
7. Pisciotta L, Oliva CP, Pes GM, Di Scala L, Bellocchio A, Fresa R et al. Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypipic comparison. Atherosclerosis 2004;188:398-405.
8. Soutar AK, Naoumova RP. Autosomal recessive hypercholesterolemia. Semin Vasc Med 2004;4:241-8.
9. Tada H, Kawashiri MA, Ohtani R, Noguchi T, Nakanishi C, Konno T et al. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene. Atherosclerosis 2011;219:663-6.
10. Jones C, Garuti R, Michaely P, Li WP, Maeda N, Cohen JC et al. Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. J Clin Invest 2007;117:165-74.
11. Tada H, Kawashiri MA, Ikewaki K, Terao Y, Noguchi T, Nakanishi C et al. Altered metabolism of low-density lipoprotein and very low-density lipoprotein remnant in autosomal recessive hypercholesterolemia: evidence from stable isotope kinetic study in vivo. Circ:Cardiovasc Genet 2012;5:35-41.
12. Inazu A, Nakajima K, Nakano T, Niimi M, Kawashiri MA, Nohara A et al. Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency. Atherosclerosis 2008;196:953-7.
13. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993;223:53-71.
14. Usui S, Hara Y, Hosaki S, Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 2002;43:805-14.
15. Kinoshita M, Kojima M, Matsushima T, Teramoto T. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta 2005;351:115-20.
16. Choi SY, Fong LG, Kirven MJ, Cooper AD. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J Clin Invest 1991;88:1173-81.
17. Ishibashi S, Perrey S, Chen Z, Osuga J, Shimada M, Ohashi K et al. Role of the Low Density Lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. J Biol Chem 1996;271:22422-7.
18. Cabezas MC, de Bruin TW, Westerveld HE, Meijer E, Erkelens DW. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia. J Intern Med 1998;244:299-307.
19. Mamo JC, Smith D, Yu KC, Kawaguchi A, Harada-Shiba M, Yamamura T et al. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia. Eur J Clin Invest 1998;28:379-84.
20. Watts GF. Postprandial lipaemia in familial hypercholesterolemia: clinical and metabolic significance. Atherosclerosis 2000;148:426-8.
21. Chan DC, Watts GF. Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box. Metabolism 2012;61:3-11.
22. Tada H, Kawashiri MA, Noguchi T, Mori M, Tsuchida M, Takata M et al. A novel method for determining functional LDL receptor activity in familial hypercholesterolemia: application of the CD3/CD28 assay in lymphocytes. Clin Chim Acta 2009;400:42-7.
23. Michaely P, Zhao Z, Li WP, Garuti R, Huang LJ, Hobbs HH et al. Identification of a VLDL-induced, FDNPVY independent internalization mechanism for the LDLR. EMBO J 2007;26:3273-82.